These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 4635563

  • 1. Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.
    Molnar GD, Taylor WF, Langworthy AL.
    Mayo Clin Proc; 1972 Oct; 47(10):709-19. PubMed ID: 4635563
    [No Abstract] [Full Text] [Related]

  • 2. Long-term results with oral hypoglycemic drugs.
    Moss JM, DeLawter DE.
    J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
    [No Abstract] [Full Text] [Related]

  • 3. Clinical pharmacology of oral antidiabetic agents (first of two parts).
    Shen SW, Bressler R.
    N Engl J Med; 1977 Mar 03; 296(9):493-7. PubMed ID: 319363
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insulin-independent diabetes mellitus.
    Bricker LA, Mintz DH.
    Med Clin North Am; 1971 Mar 03; 55(2):295-304. PubMed ID: 4926053
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R, Wendorff HJ, Field JB.
    J Clin Endocrinol Metab; 1978 Apr 03; 46(4):519-27. PubMed ID: 755038
    [No Abstract] [Full Text] [Related]

  • 11. Mild familial diabetes with dominant inheritance.
    Tattersall RB.
    Q J Med; 1974 Apr 03; 43(170):339-57. PubMed ID: 4212169
    [No Abstract] [Full Text] [Related]

  • 12. Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes.
    Turtle JR.
    Br Med J; 1970 Sep 12; 3(5723):606-10. PubMed ID: 5470087
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Attempts to delay the progression of chemical diabetes.
    Jimenez JA, Oppermann W, De Lellis RH, Camerini-Dávalos RA.
    Adv Metab Disord; 1970 Sep 12; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
    Little JA, Lee R, Sebriakova M, Csima A.
    Diabetes; 1977 Oct 12; 26(10):980-8. PubMed ID: 561729
    [No Abstract] [Full Text] [Related]

  • 18. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G, Krummel E.
    Arzneimittelforschung; 1969 Jul 12; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.